These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 32145386)
1. Remdesivir as a possible therapeutic option for the COVID-19. Al-Tawfiq JA; Al-Homoud AH; Memish ZA Travel Med Infect Dis; 2020; 34():101615. PubMed ID: 32145386 [No Abstract] [Full Text] [Related]
2. Rapid review for the anti-coronavirus effect of remdesivir. Li Z; Wang X; Cao D; Sun R; Li C; Li G Drug Discov Ther; 2020; 14(2):73-76. PubMed ID: 32378648 [TBL] [Abstract][Full Text] [Related]
4. [Remdesivir for patients with COVID-19]. Augustin M; Hallek M; Nitschmann S Internist (Berl); 2020 Aug; 61(8):869-872. PubMed ID: 32572516 [No Abstract] [Full Text] [Related]
5. Arguments in favour of remdesivir for treating SARS-CoV-2 infections. Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516 [No Abstract] [Full Text] [Related]
6. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug? Thalha AMM; Lee YY; Besari A; Omar SFS J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289 [No Abstract] [Full Text] [Related]
7. Efficacy of Remdesivir in COVID-19. McCreary EK; Angus DC JAMA; 2020 Sep; 324(11):1041-1042. PubMed ID: 32821934 [No Abstract] [Full Text] [Related]
8. Pulmonary administration of remdesivir in the treatment of COVID-19. Rasmussen HB; Hansen PR; Taboureau O; Thomsen R; Jürgens G AAPS J; 2020 Sep; 22(6):121. PubMed ID: 32944838 [No Abstract] [Full Text] [Related]
9. Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply. Beigel JH; Tomashek KM; Dodd LE N Engl J Med; 2020 Sep; 383(10):994. PubMed ID: 32649078 [No Abstract] [Full Text] [Related]
10. Remdesivir for the Treatment of Covid-19 - Preliminary Report. Olalla J N Engl J Med; 2020 Sep; 383(10):993-994. PubMed ID: 32649077 [No Abstract] [Full Text] [Related]
11. Remdesivir for the Treatment of Covid-19 - Preliminary Report. McCaw ZR; Kim DH; Wei LJ N Engl J Med; 2020 Sep; 383(10):993. PubMed ID: 32649076 [No Abstract] [Full Text] [Related]
12. Remdesivir for the Treatment of Covid-19 - Preliminary Report. McMahon JH; Udy A; Peleg AY N Engl J Med; 2020 Sep; 383(10):992-993. PubMed ID: 32649075 [No Abstract] [Full Text] [Related]
13. Remdesivir for the Treatment of Covid-19 - Preliminary Report. Gillenwater S; Rahaghi F; Hadeh A N Engl J Med; 2020 Sep; 383(10):992. PubMed ID: 32649074 [No Abstract] [Full Text] [Related]
16. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. de Wit E; Feldmann F; Cronin J; Jordan R; Okumura A; Thomas T; Scott D; Cihlar T; Feldmann H Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6771-6776. PubMed ID: 32054787 [TBL] [Abstract][Full Text] [Related]
17. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Wang M; Cao R; Zhang L; Yang X; Liu J; Xu M; Shi Z; Hu Z; Zhong W; Xiao G Cell Res; 2020 Mar; 30(3):269-271. PubMed ID: 32020029 [No Abstract] [Full Text] [Related]
18. Remdesivir and COVID-19: What are the implications for Africa? Green RJ; Mustafa F; Sewlall N; Richards GA S Afr Med J; 2020 May; 110(6):12942. PubMed ID: 32880546 [No Abstract] [Full Text] [Related]
19. Remdesivir and COVID-19. Glaus MJ; Von Ruden S Lancet; 2020 Oct; 396(10256):952. PubMed ID: 33010831 [No Abstract] [Full Text] [Related]